Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-02-16Clinical Trial Update: CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision [NA]
The CONNECT study evaluated a remote notification system to reduce time to clinical decision in patients with arrhythmia-related conditions.…
-
FDA approval · 2011-02-11FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin [Phase 2]
Phase 2 trial comparing dabigatran, with and without aspirin, to warfarin for stroke prevention in atrial fibrillation; results have been po…
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate [Phase 3]
Phase 3 randomized trial update (RE-LY) evaluating long-term anticoagulation with dabigatran etexilate for atrial fibrillation and stroke; t…
-
CLINICAL_TRIALS trial_result · 2011-02-08Clinical Trial Update: Effectiveness of Pulmonary Vein Isolation in Prevention of Atrial Fibrillation Following Heart Bypass Surgery [Phase 3]
Phase 3 trial evaluating the effectiveness of pulmonary vein isolation to prevent atrial fibrillation after heart bypass surgery (CABG) has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-02-03FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) submitted by Legacy Pharma USA, Inc., resulting in updated labe…
-
CLINICAL_TRIALS trial_result · 2011-02-03Clinical Trial Update: Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048 [Phase 2]
Long-term, open-label follow-up data are being reported for atrial fibrillation patients who were previously treated with BIBR 1048 in a Pha…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: Effect of BMS-914392 on Pharmacokinetics of Metoprolol [Phase 1]
A Phase 1 study evaluating the effect of BMS-914392 on the pharmacokinetics of metoprolol in patients with atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: Effect of Diltiazem on Pharmacokinetics of BMS-914392 [Phase 1]
Phase 1 trial assessing whether diltiazem alters the pharmacokinetics of BMS-914392 in individuals with atrial fibrillation.
-
FDA approval · 2011-01-31FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2011-01-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Diltiazem Hydrochloride from Teva Pharmaceuticals USA, Inc., updating the product's regulato…
-
CLINICAL_TRIALS trial_result · 2011-01-20Clinical Trial Update: A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation [Phase 2]
Phase 2 trial evaluating the safety and tolerability of YM150 compared with warfarin in atrial fibrillation has completed.
-
FDA approval · 2011-01-20FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for diltiazem hydrochloride (Apotex Corp.), a generic calcium channel blocker. The approval covers t…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm [NA]
A clinical trial compares amiodarone with dronedarone for maintenance of sinus rhythm after cardioversion in atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin [Phase 2]
Phase 2 dose-response study comparing dabigatran etexilate to warfarin in non-valvular atrial fibrillation completed; results posted in 2010…
-
CLINICAL_TRIALS trial_result · 2010-12-15Clinical Trial Update: Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias [Phase 4]
A Phase 4 clinical trial evaluating ajmaline for the diagnosis and treatment of cardiac arrhythmias has completed, including assessments in …
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: An Interaction Study With Digoxin and AZD1305 [Phase 1]
A Phase 1 interaction study evaluating digoxin with AZD1305 in atrial fibrillation has been completed.
-
FDA approval · 2010-11-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA's entry shows a supplemental application submission for Cardizem LA (diltiazem hydrochloride extended-release). The sponsor is Bausch He…
-
FDA approval · 2010-11-22FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2010-11-15Clinical Trial Update: Long Term Open Follow-up With H376/95 vs. Warfarin [Phase 2]
Phase 2 long-term open-follow-up comparing H376/95 to Warfarin for stroke prevention in patients with atrial fibrillation. The study status …
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events
This clinical trial update indicates that a study evaluating whether D-dimer levels can predict cardiovascular events in patients with atria…
-
FDA approval · 2010-10-18FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited to market its generic product.
-
FDA approval · 2010-10-18FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Strides Pharma Science Limited)
FDA approved Propafenone hydrochloride from Strides Pharma Science Limited under an Original Application, making a generic antiarrhythmic av…
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I) [Phase 3]
Phase 3 clinical trial update for ACTIVE I (Atrial Fibrillation Clopidogrel Trial With Irbesartan) assessing prevention of vascular events; …
-
CLINICAL_TRIALS trial_result · 2010-10-15Clinical Trial Update: Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Lovaza (omega-3-acid ethyl esters) in recurrent, symptomatic atrial fibrillation complet…